analyzeportfolio
NYSE · Financials

MOLINA HEALTHCARE, INC. (MOH)

As-reported financials and SEC filings for MOLINA HEALTHCARE, INC. The latest annual period is FY2025. The latest reported quarter is Q2 FY2026. Financial statements come straight from the company’s EDGAR filings; valuation figures such as P/E and market cap use market data.

About MOLINA HEALTHCARE, INC.

Molina Healthcare, Inc. provides managed healthcare services primarily through government-sponsored programs including Medicaid, Medicare, and state insurance marketplaces. The company serves approximately 5.5 million members across 21 states, focusing on low-income families and individuals. Molina's services include health plans designed to offer cost-effective care and access to medical services for its members.

Snapshot

Revenue
$45.43B
Revenue growth (YoY)
11.7%
Net income
$472.0M
Diluted EPS
$8.92
Gross margin
13.1%
Operating margin
1.7%
Net margin
1.0%
FCF margin
-1.4%
ROE
11.6%
net income / fiscal-year-end equity
P/E
1269.1×
trailing when available, otherwise FY EPS
Market cap
$10.60B
Long-term debt / equity
0.93×
non-current term debt only

Fundamentals are from SEC filings for FY2025, the latest annual period (ended December 31, 2025). P/E and market cap are derived from stored market prices, last retrieved on a rolling basis and typically within the past week.

What changed at Molina Healthcare

  • Revenue grew 11.7% to $45.4B in FY2025, slower than the 19.3% the year before.
  • Operating margin is 1.7% in FY2025, -2.0 pp against 3.7% in FY2021.
  • Most recent quarter Q2 FY2026: revenue $10.9B, down 4.8% from Q2 FY2025.
  • Free cash flow was negative $636M in FY2025.
  • Net income fell 60.0% to $472M in FY2025.

Computed from the as-reported figures in the statements below. A change we cannot state from filed figures is left out rather than estimated.

Peer comparison

Where Molina Healthcare’s fundamentals sit among the 425 Financials companies. Each figure is ranked only against peers that report it, from lowest (left) to highest (right).

Gross margin13.1%
16th percentile of 51
Operating margin1.7%
34th percentile of 146
Net margin1.0%
18th percentile of 377
FCF margin-1.4%
18th percentile of 272
Revenue growth (YoY)+11.7%
56th percentile of 420
ROE11.6%
63rd percentile of 375
P/E1269.1×
Highest of 318
Long-term debt / equity0.93×
77th percentile of 194
Short interest4.82d
60th percentile of 420

Molina Healthcare’s P/E of 1269.1 is the highest of the 318 peers with a meaningful P/E.

No reported insider transactions (codes P/S) in the last 90 days. For context, about 15% of companies in the universe saw any reported insider purchase (code P) in the same window. Browse insider activity →

Percentiles describe where a figure sits among sector peers reporting it (100th = highest). They are position within a peer group, not a rating, and not investment advice. Short interest ranking uses days to cover from FINRA Consolidated Short Interest data; FINRA is the owner and source of that data, included at no additional charge.

Institutional ownership

Held by 5 of the superinvestors we track (plus 6 quant / multi-strat books), based on each investor’s most recent 13F; periods vary by investor (newest: Q2 2026).

Conviction investors
5
+6 quant / multi-strat
Initiated / added
7
1 new, 6 added
Reduced / exited
5
3 trimmed, 2 exited
Combined position
$1.66B
reported long value
InvestorAs ofPosition valueSharesChange
AQR Capital ManagementquantQ2 2026$806.9M3.6MAdded
Two Sigma InvestmentsquantQ2 2026$289.6M1.3MReduced
Harris Associates (Oakmark)Q2 2026$219.0M957.5KReduced
Baupost GroupQ2 2026$144.9M633.6KHeld
Renaissance TechnologiesquantQ2 2026$72.1M315.1KAdded
D. E. ShawquantQ2 2026$47.6M208.0KAdded
Gotham Asset ManagementQ2 2026$29.9M130.5KAdded
Scion Asset ManagementQ3 2025$23.9M125.0KNew
Millennium ManagementquantQ2 2026$19.0M82.9KAdded
Citadel AdvisorsquantQ2 2026$9.8M42.7KReduced
Bridgewater AssociatesQ2 2026$1.9M8.3KAdded

No longer held by: Maverick Capital (as of Q2 2026), Point72 Asset Management (as of Q2 2026)

From quarterly Form 13F filings, which can be up to 45 days delayed. Long US-listed positions only: excludes short positions, options, cash, bonds, and non-US holdings, so this is not a manager’s complete portfolio. Counts are of the investors we track, not all institutions. Not investment advice.

Recent insider activity

Non-derivative buys and sells (codes P/S) reported by officers, directors and 10% owners on SEC Form 4.

Buys (90d)
0
code P
Bought (90d)
code P value
Sells (90d)
0
Reported activity
Quiet
by $ value, 90d
Trade dateInsiderTypeSharesPriceValue
2026-05-14
filed 2026-05-15
HEBERT MAURICEChief Accounting OfficerSell600$191.55$115K
2026-05-11
filed 2026-05-13
Barlow Jeff D.Chief Legal OfficerSell17.8K$186.12$3.3M

Reported non-derivative purchases and sales (codes P/S) — which may be open-market or private; excludes option exercises, grants, and shares withheld for taxes. Dates shown are the trade date; a Form 4 can be filed days to years later. A sale can be routine (e.g. a pre-set 10b5-1 plan), so read individual transactions in context. From SEC Form 4. Not investment advice.

Short interest

Total shares sold short as of each twice-monthly FINRA settlement. Rising short interest means more investors are positioned against the stock; days to cover estimates how many trading days of average volume that position represents.

Shares short
2.8M
settled 2026-08-14
Change vs prior
-5.3%
vs previous settlement
Days to cover
4.82
at avg daily volume
Avg daily volume
577.7K
FINRA reported
SettlementShares shortChangeDays to cover
2026-08-142.8M-5.3%4.82
2026-07-312.9M-12.0%1.43
2026-07-153.3M+1.4%3.49
2026-06-303.3M+9.7%2.72
2026-06-153.0M+18.4%3.05
2026-05-292.5M-12.9%2.68
2026-05-152.9M-18.3%3.12
2026-04-303.6M+15.7%2.06

Source: FINRA Consolidated Short Interest. FINRA is the owner and source of the FINRA-supplied data, which is included at no additional charge for your own personal or professional use; republishing or redistributing it is not permitted. Settlement dates are shown; FINRA publishes each settlement about nine business days later, so the latest figure can be two to four weeks old. Not presented as a percentage of float. No FINRA endorsement of this product is implied. Not investment advice.

Income statement (as reported)

 FY2025FY2024FY2023FY2022FY2021
Revenue$45.43B$40.65B$34.07B$31.97B$27.77B
Gross profit$5.94B$6.22B$5.40B$4.80B$4.07B
Operating income$781.0M$1.71B$1.57B$1.17B$1.02B
Net income$472.0M$1.18B$1.09B$792.0M$659.0M
Diluted EPS$8.92$20.42$18.77$13.55$11.25

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.

Balance sheet (as reported)

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.

Cash flow (as reported)

 FY2025FY2024FY2023FY2022FY2021
Operating cash flow$-535.0M$644.0M$1.66B$773.0M$2.12B
Capital expenditure$101.0M$100.0M$84.0M$91.0M$77.0M
Free cash flow$-636.0M$544.0M$1.58B$682.0M$2.04B

Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.

Quarterly trend (as reported)

QuarterRevenueRevenue YoYNet incomeDiluted EPS
Q2 FY2026$10.87B-4.8%$60.0M$1.19
Q1 FY2026$10.80B-3.1%$14.0M$0.27
Q4 FY2025$11.38B8.3%$-160.0M$-3.15
Q3 FY2025$11.48B11.0%$79.0M$1.51
Q2 FY2025$11.43B15.7%$255.0M$4.75
Q1 FY2025$11.15B12.2%$298.0M$5.45
Q4 FY2024$10.50B16.0%$251.0M$4.44
Q3 FY2024$10.34B21.0%$326.0M$5.65

Latest 8 reported quarters, from company XBRL filings on SEC EDGAR.

Company facts

ExchangeNYSE
SectorFinancials
SIC industryHospital & Medical Service Plans
Latest annual periodFY2025 (ended December 31, 2025)
Latest reported quarterQ2 FY2026 (ended June 30, 2026)
Oldest indexed filing2017
SEC CIK1179929

Selected SEC filings

10-Q2026-07-23
View on EDGAR →
10-Q2026-04-23
View on EDGAR →
10-Q2025-10-23
View on EDGAR →
8-K2026-07-22
View on EDGAR →
8-K2026-06-10
View on EDGAR →
8-K2026-05-11
View on EDGAR →
8-K2026-05-08
View on EDGAR →

Largest Financials peers

All Financials companies →

Monitor MOH

Get an alert when Molina Healthcare files something material, see which superinvestors own it, and ask its filings a question with cited answers.

Monitor MOH free

Includes one free filing-grounded research answer. Or check your whole portfolio, no account needed.

Data sourced from SEC EDGAR. Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only. Not investment advice.